Large Cell Neuroblastoma: A Distinct Phenotype of Neuroblastoma with Aggressive Clinical Behavior

Cancer

Volumn 100, Issue 2, 2004, Pages 390-397

  Tornóczky, Tamás ^a,b   Kálmán, Endre ^a   Kajtár, Pál G ^a   Nyári, Tibor ^b,c   Pearson, Andrew D J ^b   Tweddle, Deborah A ^b   Board, Julian ^b   Shimada, Hiroyuki ^d  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SZEGED   (Hungary)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

International Neuroblastoma Pathology Classification; Large cell; MYCN; Neuroblastic; Neuroblastoma; Nucleolus; Phenotype

Indexed keywords

ENOLASE; GENE PRODUCT; SYNAPTOPHYSIN;

ARTICLE; CANCER CLASSIFICATION; CELL NUCLEUS MEMBRANE; CHILD; CLINICAL FEATURE; FEMALE; GENE; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LARGE CELL NEUROBLASTOMA; MAJOR CLINICAL STUDY; MALE; MYCN GENE; NEUROBLASTOMA; NUCLEOLUS; PHENOTYPE; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEUROBLASTOMA; PHENOTYPE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 17344388518     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20005     Document Type: Article

References (10)

1. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors. Recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349-363.
2. Brown HG, Kepner JL, Perlman EJ, et al. "Large cell/ anaplastic" medulloblastomas: a Pediatric Oncology Group study. J Neuropathol Exp Neurol. 2000;59:857-865.
3. Kato K, Kato Y, Ijiri R, et al. Ewing's sarcoma family of tumor arising in the adrenal gland-possible diagnostic pitfall in pediatric pathology: histologic, immunohistochemical, ultrastructural, and molecular study. Hum Pathol. 2001;32:1012-1016.
4. Miettinen M, Chatten J, Paetau A, Stevenson A. Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol. 1998;22:327-332.
5. Shimada H, Ambros IM, Dehner LP, et al. International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364-372.
6. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121-1124.
7. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111-1116.
8. Fong C, Dracopoli NC, White PS, et al. Loss of heterozygozity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A. 1989;86:3753-3757.
9. Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 1999;340:1954-1961.
10. Goto S, Umehara S, Gerbing RB, et al. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. A report from the Children's Cancer Group. Cancer. 2001;92:2699-2708.